BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Human chorionic gonadotropin
,
Prozac
,
rs2300478
,
ERBB2
,
cell-cell adhesion
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD137
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Exosome derived from CD137-modified endothelial cells regulates the Th17 responses in atherosclerosi…
CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolon…
Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of …
Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies.
The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Cl…
Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma
FNA Tumor Sampling for CD137 Modulation: A Pilot Study
Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma
Study of LVGN6051 (CD137 Agonist Antibody) in Advanced or Metastatic Malignancy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ